No evidence of a significant role for CTLA-4 in multiple sclerosis

J Neuroimmunol. 2006 Feb;171(1-2):193-7. doi: 10.1016/j.jneuroim.2005.10.006. Epub 2005 Dec 1.

Abstract

Variation in the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) gene plays a significant role in determining susceptibility to autoimmune thyroid disease and type 1 diabetes. Its role in multiple sclerosis is more controversial. In order to explore this logical candidate more thoroughly, we genotyped 771 multiple sclerosis trio families from the United Kingdom for the 3' untranslated region variable number tandem repeat, the CT60 single nucleotide polymorphism (SNP) and five haplotype-tagging SNPs. No individual marker or common haplotype showed evidence of association with disease. These data suggest that any effect of CTLA-4 on multiple sclerosis susceptibility is likely to be very small.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions / physiology
  • Adult
  • Antigens, CD
  • Antigens, Differentiation / genetics*
  • CTLA-4 Antigen
  • Chi-Square Distribution
  • Female
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Male
  • Minisatellite Repeats / genetics
  • Multiple Sclerosis / epidemiology
  • Multiple Sclerosis / genetics*
  • Polymorphism, Genetic / genetics*

Substances

  • 3' Untranslated Regions
  • Antigens, CD
  • Antigens, Differentiation
  • CTLA-4 Antigen
  • CTLA4 protein, human